Coronary Flow Reserve Following Orbital Atherectomy

NCT02339545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2023-07-18

Study results available
· View outcomes & findings →

Summary

The purpose of the study was to evaluate coronary artery flow reserve (CFR) following successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions by orbital atherectomy and stenting.

Conditions

Interventions

DEVICE

Coronary Orbital Atherectomy plus Stenting

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Nabil Dib, MD · Dignity Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339545 on ClinicalTrials.gov